{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:59:54Z","timestamp":1772117994070,"version":"3.50.1"},"reference-count":44,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23\u2010AR\u2010071473"],"award-info":[{"award-number":["K23\u2010AR\u2010071473"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01\u2010AR\u2010073208"],"award-info":[{"award-number":["R01\u2010AR\u2010073208"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30\u2010AR\u2010070254"],"award-info":[{"award-number":["P30\u2010AR\u2010070254"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Autoimmune responses to\n                      <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content>\n                      topoisomerase I (topo I) are found in a subset of scleroderma patients who are at high risk for interstitial lung disease (\n                      <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content>\n                      ) and mortality. Anti\u2013topo I antibodies (\n                      <jats:styled-content style=\"fixed-case\">ATA<\/jats:styled-content>\n                      s) are associated with specific\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\n                        \u2013\n                        <jats:styled-content style=\"fixed-case\">DRB<\/jats:styled-content>\n                        1\n                      <\/jats:italic>\n                      alleles, and the frequency of\n                      <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content>\n                      \u2013restricted topo I\u2013specific\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      4+ T cells is associated with the presence, severity, and progression of\n                      <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content>\n                      . Although this strongly implicates the presentation of topo I peptides by\n                      <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content>\n                      in scleroderma pathogenesis, the processing and presentation of topo I has not been studied.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We developed a natural antigen processing assay (\n                      <jats:styled-content style=\"fixed-case\">NAPA<\/jats:styled-content>\n                      ) to identify putative\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      4+ T cell epitopes of topo I presented by monocyte\u2010derived dendritic cells (mo\u2010DCs) from 6\u00a0\n                      <jats:styled-content style=\"fixed-case\">ATA<\/jats:styled-content>\n                      \u2010positive patients with scleroderma. Mo\u2010DCs were pulsed with\u00a0topo I\u00a0protein,\n                      <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content>\n                      \u2013peptide complexes were isolated, and eluted peptides were analyzed by mass spectrometry. We then examined the ability of these naturally presented peptides to induce\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      4+ T cell activation in 11\n                      <jats:styled-content style=\"fixed-case\">ATA<\/jats:styled-content>\n                      \u2010positive and 11\n                      <jats:styled-content style=\"fixed-case\">ATA<\/jats:styled-content>\n                      \u2010negative scleroderma patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that a common set of 10 topo I epitopes was presented by Mo\u2010DCs from scleroderma patients with diverse\n                      <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content>\n                      variants. Sequence analysis revealed shared peptide\u2010binding motifs within the\n                      <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content>\n                      \u03b2 chains of\n                      <jats:styled-content style=\"fixed-case\">ATA<\/jats:styled-content>\n                      \u2010positive patients and a subset of topo I epitopes with distinct sets of anchor residues capable of binding to multiple different\n                      <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content>\n                      variants. The\n                      <jats:styled-content style=\"fixed-case\">NAPA<\/jats:styled-content>\n                      \u2010derived epitopes elicited robust\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      4+ T cell responses in 73% of\n                      <jats:styled-content style=\"fixed-case\">ATA<\/jats:styled-content>\n                      \u2010positive patients (8 of 11), and the number of epitopes recognized correlated with\n                      <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content>\n                      severity (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.025).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings mechanistically implicate the presentation of a convergent set of topo I epitopes in the development of scleroderma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/art.41248","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T05:52:41Z","timestamp":1583992361000},"page":"1375-1384","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Definition of Naturally Processed Peptides Reveals Convergent Presentation of Autoantigenic Topoisomerase I Epitopes in Scleroderma"],"prefix":"10.1002","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4749-870X","authenticated-orcid":false,"given":"Eleni","family":"Tiniakou","sequence":"first","affiliation":[{"name":"Johns Hopkins University School of Medicine  Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fava","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine  Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-8940","authenticated-orcid":false,"given":"Zsuzsanna H.","family":"McMahan","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine  Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Guhr","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine  Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"O'Meally","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine  Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami A.","family":"Shah","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine  Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrick M.","family":"Wigley","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine  Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Cole","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine  Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Boin","sequence":"additional","affiliation":[{"name":"University of California  San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1119-0279","authenticated-orcid":false,"given":"Erika","family":"Darrah","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine  Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0806188"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-007-0012-3"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.062901"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2016.10.017"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118071"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200107)44:7<1654::AID-ART288>3.0.CO;2-O"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.008037"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.03.004"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0993-2"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098"},{"key":"e_1_2_7_12_1","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy EC","year":"2001","journal-title":"J Rheumatol"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1533-z"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1161"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-008-0330-2"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp033"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12889"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-019-0128-8"},{"key":"e_1_2_7_19_1","first-page":"105","article-title":"Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules","volume":"73","author":"Appella E","year":"1995","journal-title":"EXS"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.11.6720"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.6b00617"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200738011"},{"key":"e_1_2_7_23_1","first-page":"1481","article-title":"HLA markers for susceptibility and expression in scleroderma","volume":"32","author":"Gladman DD","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1246886"},{"key":"e_1_2_7_25_1","first-page":"857","article-title":"Association of HLA\u2010DR with progressive systemic sclerosis in Japanese","volume":"21","author":"Takeuchi F","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_7_26_1","first-page":"1577","article-title":"Association of HLA class II genes with systemic sclerosis in Koreans","volume":"28","author":"Kang SH","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154255"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116703"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780301102"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.03.035"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.5.1597"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830191209"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1416864111"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5465.505"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.3.367"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20022226"},{"key":"e_1_2_7_37_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.158.1.485","article-title":"Highly restricted TCR\u2010\u03b1\u03b2 usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope","volume":"158","author":"Kuwana M","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1293"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3818"},{"key":"e_1_2_7_40_1","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.156.7.2365","article-title":"Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing","volume":"156","author":"Viner NJ","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1850"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-018-0104-8"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.2.201"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpim.14"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0015-4"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.41248","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41248","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.41248","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:26:24Z","timestamp":1759947984000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.41248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1002\/art.41248"],"URL":"https:\/\/doi.org\/10.1002\/art.41248","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/798249","asserted-by":"object"}]},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"2019-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}